Wonkyung Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wonkyung Choi has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Liming Qiu
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
3 shared publications - Robert L. Seilheimer
Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
3 shared publications Andrew Chang
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
2 shared publicationsBijan Pesaran
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
2 shared publicationsCasey Halpern
2 shared publications- Gustavo Campos
Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
2 shared publications
Latest Publications
- Open Access
Patient-specific subnetwork connectivity predicts deep brain stimulation response in obsessive-compulsive disorder
Summary: Deep brain stimulation (DBS) can be an effective treatment for severe obsessive-compulsive disorder (OCD), but response is variable, and objective, reliable predictors of who will respond positively are absent. In three individuals with OCD, we implanted intracranial electrodes across the cortico-striato-limbic network before DBS. Prefrontal gamma activity, most prominently in the orbitofrontal cortex (OFC), distinguished high-from low-symptom OCD states reproducibly across days. Acute stimulation of the ventral capsule/ventral striatum relieved OCD symptoms and, in one patient, significantly shifted this OFC gamma signal. Effective connectivity from therapeutic stimulation sites to these prefrontal regions defined three patient-specific OCD subnetworks; the baseline strength of the nucleus accumbens/ventral pallidum-OFC subnetwork predicted acute and long-term DBS response. Imaging-based modeling of current propagation in stimulation-activated ventral capsule to the OFC tracked acute response, suggesting that this prediction could be approximated from imaging alone. These findings outline a predictive, subnetwork-level framework for personalized DBS in OCD. Highlights: Prefrontal gamma encodes OCD symptom state and persists across recording days Acute VC/VS stimulation relieves symptoms and can shift the prefrontal gamma signal Baseline subnetwork connectivity predicts acute and long-term DBS response Modeled ALIC-to-OFC tract activation approximates this prediction from imaging In Brief: Scangos and colleagues mapped three patients with obsessive-compulsive disorder with intracranial electrodes before deep brain stimulation. Prefrontal gamma activity tracked symptom state, and baseline connectivity from stimulation sites to these prefrontal regions predicted acute and long-term stimulation response. Modeled activation of ALIC-to-OFC tracts was associated with response, offering a route to this prediction from imaging alone. Graphical
Open AccessPatient-specific subnetwork connectivity predicts deep brain stimulation response in obsessive-compulsive disorder
Summary: Deep brain stimulation (DBS) can be an effective treatment for severe obsessive-compulsive disorder (OCD), but response is variable, and objective, reliable predictors of who will respond positively are absent. In three individuals with OCD, we implanted intracranial electrodes across the cortico-striato-limbic network before DBS. Prefrontal gamma activity, most prominently in the orbitofrontal cortex (OFC), distinguished high-from low-symptom OCD states reproducibly across days. Acute stimulation of the ventral capsule/ventral striatum relieved OCD symptoms and, in one patient, significantly shifted this OFC gamma signal. Effective connectivity from therapeutic stimulation sites to these prefrontal regions defined three patient-specific OCD subnetworks; the baseline strength of the nucleus accumbens/ventral pallidum-OFC subnetwork predicted acute and long-term DBS response. Imaging-based modeling of current propagation in stimulation-activated ventral capsule to the OFC tracked acute response, suggesting that this prediction could be approximated from imaging alone. These findings outline a predictive, subnetwork-level framework for personalized DBS in OCD. Highlights: Prefrontal gamma encodes OCD symptom state and persists across recording days Acute VC/VS stimulation relieves symptoms and can shift the prefrontal gamma signal Baseline subnetwork connectivity predicts acute and long-term DBS response Modeled ALIC-to-OFC tract activation approximates this prediction from imaging In Brief: Scangos and colleagues mapped three patients with obsessive-compulsive disorder with intracranial electrodes before deep brain stimulation. Prefrontal gamma activity tracked symptom state, and baseline connectivity from stimulation sites to these prefrontal regions predicted acute and long-term stimulation response. Modeled activation of ALIC-to-OFC tracts was associated with response, offering a route to this prediction from imaging alone. Graphical
- Open Access
- 17 October 2026
- Published by Elsevier in Brain Stimulation
- Vol. 19 (6)
A reproducible safety assessment model for concurrent transcranial magnetic stimulation with implanted intracranial electroencephalography electrodes
- 17 October 2026
- Published by Elsevier in Brain Stimulation
- Vol. 19 (6)
Open AccessA reproducible safety assessment model for concurrent transcranial magnetic stimulation with implanted intracranial electroencephalography electrodes
- 2 October 2026
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 17 (4) , 359-362
Complicating the Ethical Case Against DBS for Obesity
- 2 October 2026
- Published by Taylor & Francis in AJOB Neuroscience
- Vol. 17 (4) , 359-362
Complicating the Ethical Case Against DBS for Obesity
- Open Access
- 17 November 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (12) , 4038-4043
Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide
Obesity and related conditions are associated with distressing food preoccupation that often culminates in dysregulated eating behaviors. Incretin-based therapies can reduce excessive weight in obesity, but their impact on dysregulated eating behaviors remains largely unexamined. Understanding how these pharmacologics engage the brain’s mesolimbic circuitry may inform the expansion of their therapeutic potential. We report a rare, first-in-human exploration of the physiological action of these therapies by examining the electrophysiology directly within the human nucleus accumbens. After a short-term course of tirzepatide, the patient-participant exhibited increased severe food preoccupation episodes, which were preceded by an increased delta–theta frequency (≤7 Hz) power in the nucleus accumbens region. We propose that the effects of an incretin-based therapy (tirzepatide) on food preoccupation may be associated with modulation of aberrant activity within this key hub of human mesolimbic circuitry.
- 17 November 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (12) , 4038-4043
Open AccessBrain activity associated with breakthrough food preoccupation in an individual on tirzepatide
Obesity and related conditions are associated with distressing food preoccupation that often culminates in dysregulated eating behaviors. Incretin-based therapies can reduce excessive weight in obesity, but their impact on dysregulated eating behaviors remains largely unexamined. Understanding how these pharmacologics engage the brain’s mesolimbic circuitry may inform the expansion of their therapeutic potential. We report a rare, first-in-human exploration of the physiological action of these therapies by examining the electrophysiology directly within the human nucleus accumbens. After a short-term course of tirzepatide, the patient-participant exhibited increased severe food preoccupation episodes, which were preceded by an increased delta–theta frequency (≤7 Hz) power in the nucleus accumbens region. We propose that the effects of an incretin-based therapy (tirzepatide) on food preoccupation may be associated with modulation of aberrant activity within this key hub of human mesolimbic circuitry.